April 2 | Mon Apr 2, 2012 8:18am EDT
April 2 (Reuters) - U.S. antitrust regulators approved Express Scripts Inc's purchase of rival Medco Health Solutions Inc, the Federal Trade Commission said on Monday, following a contentious eight-month review.
The $29 billion deal, first announced in July, combines two of the three largest U.S. pharmacy benefit managers into the clear industry leader. Separately, the companies announced they completed the deal.
0 comments:
Post a Comment